Evidence map›Paper›PMID 41471181›Full record

ArticlePathogens (Basel, Switzerland)2025

IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru.

Nawal De la Peña Galindo, Silvia Capristano Valdez, Cesar Sanchez Neira, Henri Bailon Calderon, Gilmer Solis Sanchez, Flor Peceros Pelaez, Marco Galarza Perez

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Diagnostic accuracy ofFrontiers in immunology · 2026
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nawal De la Peña GalindoInnovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru.
Silvia Capristano ValdezInnovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru.
Cesar Sanchez NeiraInnovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru.
Henri Bailon CalderonInnovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru.
Gilmer Solis SanchezHealth Technology Assessment Center, Instituto Nacional de Salud, Lima 15046, Peru.
Flor Peceros PelaezVirology Unit, Instituto Nacional de Salud, Lima 15046, Peru.
Marco Galarza PerezInnovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru.ORCID 0000-0002-6547-2354

Funding

Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica Convenio N° 018-2019-FONDECYT
6 · The paper itself

Abstract

backgroundPeru ranks among the countries with the highest burden of tuberculosis in Latin America. Interferon Gamma Release Assays (IGRAs), such as QuantiFERON-TB (QFT), cannot distinguish latent tuberculosis infection (LTBI) from active tuberculosis (ATB), but they provide a more specific and quantitative assessment of prior exposure to

methodsWe enrolled 56 participants and measured 38 cytokines/chemokines from plasma obtained through QFT in patients with active TB (n = 11), LTBI (n = 17), and QFT-negative healthy controls (n = 28) using a Multiplex Bead Assay.

resultsLevels of IL-1RA, IL-2, IL-5, IFN-γ, and IP-10 significantly differentiated both ATB and LTBI groups from healthy controls (

conclusionsBeyond IFN-γ as a differential proinflammatory cytokine in TB, cytokines such as IL-5, and IP-10 show potential as biomarkers to discriminate infection status in high-burden TB settings.

Indexed as

Chemokine CXCL10Interleukin-5Latent TuberculosisAdolescentAdultBiomarkersFemaleHumansInterferon-gammaInterferon-gamma Release TestsMaleMiddle AgedMycobacterium tuberculosisPeruYoung AdultBiomarkersChemokine CXCL10CXCL10 protein, humanIL5 protein, humanInterferon-gammaInterleukin-5chemokinescytokinesIGRAslatent tuberculosis

Identifiers

PMID41471181
PMCPMC12735898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.